Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
Aims/hypothesis: The macrophage-specific glycoprotein sCD163 has emerged as a biomarker of low-grade inflammation in the metabolic syndrome and related disorders. High sCD163 levels are seen in acute sepsis as a result of direct lipopolysaccharide-mediated shedding of the protein from macrophage sur...
Main Authors: | Ermina Bach, Niels Møller, Jens Otto L Jørgensen, Mads Buhl, Holger Jon Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2019-02-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/8/2/EC-18-0554.xml |
Similar Items
-
Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial
by: Nikolaj Rittig, et al.
Published: (2018-01-01) -
Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients
by: Ninna Aggerholm-Pedersen, et al.
Published: (2023-02-01) -
Increased Serum Levels of sCD14 and sCD163 Indicate a Preponderant Role for Monocytes in COVID-19 Immunopathology
by: Jose Gómez-Rial, et al.
Published: (2020-09-01) -
PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS
by: hend Attia
Published: (2023-08-01) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
by: Marlene Christina Nielsen, et al.
Published: (2020-05-01)